SUPN
Supernus Pharmaceuticals Inc
Price:  
26.97 
USD
Volume:  
226,397.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Relative Valuation

-50.5%
Upside

As of 2023-11-29, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 13.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.97 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -50.5%.

The range of the Relative Valuation is 8.68 - 19.39 USD.

Range Selected
Trailing P/E multiples 18.5x - 23.3x 19.4x
Forward P/E multiples 19.9x - 24.1x 21.9x
Fair Price 8.68 - 19.39 13.36
Upside -67.8% - -28.1% -50.5%
26.97 USD
Stock Price
13.36 USD
Fair Price

SUPN Relative Valuation - Historical P/E Data

Date P/E
2023-11-28 57.51
2023-11-27 57.77
2023-11-24 59.35
2023-11-22 58.45
2023-11-21 58.07
2023-11-20 58.24
2023-11-17 58.49
2023-11-16 59.45
2023-11-15 60.97
2023-11-14 59.79
2023-11-13 58.28
2023-11-10 56.83
2023-11-09 55.74
2023-11-08 50.15
2023-11-07 50.88
2023-11-06 51.24
2023-11-03 52.20
2023-11-02 51.33
2023-11-01 50.99
2023-10-31 50.86
2023-10-30 50.37
2023-10-27 50.24
2023-10-26 48.45
2023-10-25 49.58
2023-10-24 51.18
2023-10-23 50.67
2023-10-20 51.84
2023-10-19 50.71
2023-10-18 53.80
2023-10-17 55.34
2023-10-16 55.06
2023-10-13 52.97
2023-10-12 55.10
2023-10-11 57.70
2023-10-10 58.28
2023-10-09 58.39
2023-10-06 58.51
2023-10-05 58.34
2023-10-04 57.38
2023-10-03 57.77
2023-10-02 57.83
2023-09-29 58.79
2023-09-28 59.88
2023-09-27 60.94
2023-09-26 62.29
2023-09-25 60.90
2023-09-22 60.07
2023-09-21 58.92
2023-09-20 58.98
2023-09-19 60.65